Dr Aaron Wernham is a Consultant Dermatologist and Mohs surgeon at Walsall Healthcare NHS Trust and The Royal Wolverhampton NHS Trust. He is a steering committee member for the UK Dermatology Clinical Trials Network (UKDCTN) and past associate Editor for the CED Journal. He co-led a Priority Setting Partnership in skin cancer surgery and the CANVAS suture study, and is a trial team member for the OASIS and PAUSE studies. He is co-CI for the HEALS2 study assessing the benefit of compression for secondary intention wounds post-skin cancer surgery.